4.25↑0.00 (0.00%)
10th Dec 201470.7000↑ (%)
2nd Jul 2007BSE : 506985
NSE : TWILITAKA
Sector :
ISIN Code :
Last Updated: Jul 02 2007 | 12:00 AM IST
Market Cap (₹ Cr) | NaN |
Turnover (₹ Cr) | NaN |
Volume (Shares) | 8892 |
52-WK High | 4.45 |
52-WK High Date | 26 Sep 2023 |
52-WK Low | 0.00 |
52-WK Low Date | 26 Sep 2023 |
All Time High | |
All Time High Date | 26 Sep 2023 |
All Time Low | |
All Time Low Date | 26 Sep 2023 |
Incorporated as a private limited company in Jan.'74 Li Taka Pharmaceuticals was converted into a public limited company in Dec.'85. Li Taka Laboratories Pvt Ltd was amalgamated with the company in 1986.The company is engaged in the manufacture of various drugs and pharmaceuticals formulations. It also manufactures formulations on loan licence basis as well as on principal to principal basis for various multinational companies like Hindustan Ciba Geigy Pfizer and Burroughs Wellcome. Its manufacturing facility is located at Pimpri Pune.The company came out with a rights issue in Apr.'92 to meet the long-term working capital requirements of the company and to part-finance its normal capital expenditure including modernisation.In Jun.'95 Pegasus Laboratories was amalgamated with the company. The company exported goods worth Rs 1.14 cr in 1996-97.During 1997-98 the company has purchased Marketing division of Borachem Industries Ltd. With this arrangement the company's product will be represented in almost all the major parts of the country. There is a rise of 88.53% in the sales over the previous year. To give more emphasis on own operations the marketing alliance with Smithkline Beecham Pharmaceuticlas (I) Ltd. has been terminated.The company is planning to introduce new products for domestic and internation market.
PARAMETER | VALUES |
---|---|
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Year Low/High | 0.00 0.00 |
All time Low/High | 1.35 204.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
% | % | % |
Date | Client Name | Exchange | Transaction | Quantity | Price |
---|---|---|---|---|---|
28-03-2013 | Fervent Pharma Synergies Limited | BSE | SELL | 183030 | 5.60 |
04-02-2013 | KAMAL CHANDMAL JAIN | BSE | SELL | 125000 | 9.48 |
03-05-2011 | IFCI FACTORS LTD | BSE | SELL | 137521 | 54.96 |
25-03-2011 | IFCI FACTORS LTD | BSE | SELL | 171500 | 52.43 |
24-03-2011 | IFCI FACTORS LTD | BSE | SELL | 250000 | 50.44 |
23-03-2011 | IFCI FACTORS LTD | BSE | SELL | 125000 | 45.31 |
16-03-2011 | PAM PAC MACHINES PRIVATE LIMITED | BSE | SELL | 250000 | 47.89 |
15-03-2011 | PAM PAC MACHINES PRIVATE LIMITED | BSE | SELL | 190000 | 54.04 |
14-12-2010 | ECL FINANCE LIMITED | BSE | SELL | 200000 | 75.80 |
14-12-2010 | KARVY FINANCIAL SERVICES LIMITED | BSE | SELL | 231000 | 82.09 |
Load More |
Announcement Date | Purpose | From | To | Remarks |
---|---|---|---|---|
Data Not Found |
Search for Price History
Date | Open | High | Low | Close | Shares | Trades |
---|---|---|---|---|---|---|
Data Not Found |
Load more
Chairman : R C Bora
Managing Director : Gopal Ramourti
Executive Director & CFO : N R Bora
Director : A S Chandvankar
Director : M S Raghavan Ayyangar